Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary

NCT02429570 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Brain Metastases
Progressive Brain Metastases

Interventions

DRUG: Meclofenamate

Sponsor

Memorial Sloan Kettering Cancer Center